Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare stocks are hot right now. The S&P 500 Health Care index has gained 3% over the last 12 months versus the 8% decline of the broader S&P 500 benchmark index . Reasons that healthcare stocks have outper...
IQVIA Holdings ( NYSE: IQV ) has traded as much as 3% down in Friday trading after releasing 2023 guidance figures after Thursday's closing bell that came in below consensus estimates. In 2023, the analytics and clinical research services provider is projecting revenue of between ...
IQVIA Holdings (IQV) Q4 2022 Earnings Conference Call February 10, 2023 9:00 a.m. ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Treasurer Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President a...
IQVIA press release ( NYSE: IQV ): Q4 Non-GAAP EPS of $2.78 beats by $0.02 . Revenue of $3.74B (+2.7% Y/Y) beats by $30M . For FY2023, the company expects revenue to be between $15.15B and $15.4B vs. consensus of $15.41B; Adjusted EBITDA to be between $.625B and $3.6...
Revenue of $3,739 million for the fourth quarter, $14,410 million for the full year GAAP Net Income of $227 million for the fourth quarter, $1,091 million for the full year Adjusted EBITDA of $920 million for the fourth quarter, $3,346 million for the full year GAAP Dilute...
IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, has been named to FORTUNE magazine’s “World’s Most Admired Companies” list for the sixth consecutive year. ...
IQVIA ( NYSE: IQV ) is scheduled to announce Q4 earnings results on Friday, February 10th, before market open. The consensus EPS Estimate is $2.76 (+8.2% Y/Y) and the consensus Revenue Estimate is $3.71B (+1.9% Y/Y). Over the last 2 years, IQV has beaten EPS estimates 100%...
The shares for Doximity (NYSE: DOCS) , Iqvia Holdings (NYSE: IQV) , and TransMedics Group (NASDAQ: TMDX) are all off to positive starts this year, but what makes them different from other companies is that they are changing healthcare industry standards. Doximity i...
Summary William von Mueffling's 13F portfolio value increased this quarter from $11.04B to $11.81B. Cantillon added CDW Corp and increased BlackRock, Interactive Brokers, Entegris, and Armstrong World Industries during the quarter. The portfolio continues to be very concentrated wit...
IQVIA ( NYSE: IQV ) announces the first life sciences industry collaboration with Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, in China. The two companies will be providing solutions hosted in Mainland China leveraging Salesforce on Alibab...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...